Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase II Study of 18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma

NCT04813705 is registered in ClinicalTrials.gov with Taizhou Hospital as lead sponsor.

NCT NCT04813705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04813705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase II Study of 18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
Lead sponsor
Taizhou Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
January 1, 2022
Completion date
June 30, 2029
Enrollment
93 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal carcinoma